Foresight Global Investors’s AstraZeneca AZN Stock Holding History

Foresight Global Investors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.5M	Sell	118,844 -26,453	-18%	-$4.98M	13.66%	2
2026 Q1	$28.7M	Sell	145,297 -39	-0%	-$7.52K	18.6%	1
2025 Q4	$51M	Buy	145,336 +23,747	+20%	+$4.16M	24.01%	1
2025 Q3	$18.7M	Buy	+121,589	New	+$18.4M	11.08%	3
2024 Q1	–	Sell	-129,014	Closed	-$17.4M	–	42
2023 Q4	$17.4M	Sell	129,014 -4,851	-4%	-$631K	9.96%	2
2023 Q3	$18.1M	Buy	133,865 +6,992	+6%	+$955K	10.09%	1
2023 Q2	$18.2M	Sell	126,873 -16,560	-12%	-$2.44M	9.8%	1
2023 Q1	$19.9M	Buy	+143,433	New	+$19.3M	14.27%	2

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Foresight Global Investors's AZN Position: Q2 2026 in Review

Foresight Global Investors reduced its AstraZeneca (AZN) stake by 18% in Q2 2026, selling an estimated $4.98M and leaving 118,844 shares worth $22.5M. The position accounts for 13.66% of the portfolio, ranked #2.

Foresight Global Investors first reported a position in AZN in Q1 2023 and has held it in 8 quarters since. The position peaked at $51M in Q4 2025. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Foresight Global Investors held 118,844 shares of AstraZeneca worth $22.5M as of Q2 2026.
Foresight Global Investors sold 26,453 AstraZeneca shares in Q2 2026, an estimated $4.98M.
AstraZeneca made up 13.66% of Foresight Global Investors's portfolio in Q2 2026, its #2 holding.
Foresight Global Investors first reported a position in AstraZeneca in Q1 2023 and has held it in 8 quarters since.
Foresight Global Investors's AstraZeneca position peaked at $51M in Q4 2025.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Foresight Global Investors's 13F filing for Q2 2026, filed 11 Aug 2026.